Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 264,547 | 167,944 | 121,356 | 102,312 |
| General And Administrative Expense | 264,547 | 167,944 | 121,356 | 102,312 |
| Other Operating Expenses | 34,828 | 48,605 | 20,889 | 15,969 |
| Operating Expense | 299,375 | 216,549 | 142,245 | 118,281 |
| Operating Income | -299,375 | -216,549 | -142,245 | -118,281 |
| EBIT | -299,375 | -216,549 | -142,245 | -118,281 |
| Interest Expense | -- | -- | -- | 0.00 |
| Interest Expense Non Operating | -- | -- | -- | 0.00 |
| Interest Income | 21,764 | 0.00 | -- | -- |
| Interest Income Non Operating | 21,764 | 0.00 | -- | -- |
| Net Interest Income | 21,764 | 0.00 | -- | 0.00 |
| Other Income Expense | 121,469 | 779,779 | 530,828 | 196,061 |
| Other Non Operating Income Expenses | -- | -- | 509,000 | 137,500 |
| Special Income Charges | -13,748 | 809,195 | 498,142 | 123,282 |
| Write Off | 0.00 | -82,468 | 0.00 | -- |
| Gain On Sale Of Security | 135,217 | -29,416 | 32,686 | 72,779 |
| Pretax Income | -156,142 | 563,230 | 388,583 | 77,780 |
| Tax Effect Of Unusual Items | 0.00 | 311,912 | 139,130 | 51,956 |
| Net Income From Continuing And Discontinued Operation | -156,142 | 563,230 | 388,583 | 77,780 |
| Net Income From Continuing Operation Net Minority Interest | -156,142 | 563,230 | 388,583 | 77,780 |
| Net Income Including Noncontrolling Interests | -156,142 | 563,230 | 388,583 | 77,780 |
| Net Income Common Stockholders | -156,142 | 563,230 | 388,583 | 77,780 |
| Net Income | -156,142 | 563,230 | 388,583 | 77,780 |
| EBITDA | -299,375 | -216,549 | -142,245 | -118,281 |
| Normalized EBITDA | -420,844 | -996,328 | -673,073 | -314,342 |
| Basic EPS | -0.01 | 0.04 | 0.04 | 0.01 |
| Diluted EPS | -0.01 | 0.04 | 0.04 | 0.01 |
| Basic Average Shares | 18.5M | 14.1M | 8.9M | 8.9M |
| Diluted Average Shares | 18.5M | 14.1M | 8.9M | 8.9M |
| Total Unusual Items | 121,469 | 779,779 | 530,828 | 196,061 |
| Total Unusual Items Excluding Goodwill | 121,469 | 779,779 | 530,828 | 196,061 |
| Tax Rate For Calcs | 0.00 | 0.40 | 0.26 | 0.27 |
| Normalized Income | -277,611 | 95,363 | -3,115 | -66,325 |
| Diluted NI Availto Com Stockholders | -156,142 | 563,230 | 388,583 | 77,780 |
| Gain On Sale Of Ppe | 0.00 | 738,000 | 509,000 | 137,500 |
| Impairment Of Capital Assets | 13,748 | 11,273 | 10,858 | 14,218 |
| Insurance And Claims | 7,500 | 0.00 | -- | -- |
| Net Income Continuous Operations | -156,142 | 563,230 | 388,583 | 77,780 |
| Net Non Operating Interest Income Expense | 21,764 | 0.00 | -- | 0.00 |
| Other Gand A | 110,021 | 138,204 | 121,356 | 102,312 |
| Salaries And Wages | 147,026 | 29,740 | 0.00 | -- |
| Total Expenses | 299,375 | 216,549 | 142,245 | 118,281 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 809,931 | 747,962 | 198,970 | 18,962 |
| Cash Cash Equivalents And Short Term Investments | 1.8M | 1.9M | 965,260 | 526,462 |
| Cash Financial | 809,931 | 747,962 | 198,970 | 18,962 |
| Other Short Term Investments | 943,053 | 1.2M | 766,290 | 507,500 |
| Accounts Receivable | 27,682 | 32,011 | 5,106 | 2,637 |
| Receivables | 27,682 | 32,011 | 5,106 | 2,637 |
| Current Assets | 1.8M | 2.0M | 970,366 | 529,099 |
| Net PPE | 2.2M | 2.0M | 1.9M | 1.9M |
| Total Non Current Assets | 2.2M | 2.0M | 1.9M | 1.9M |
| Total Assets | 4.0M | 4.0M | 2.9M | 2.4M |
| Accounts Payable | 38,916 | 20,783 | 26,168 | 39,643 |
| Payables | 41,882 | 26,106 | 797,701 | 712,295 |
| Payables And Accrued Expenses | 41,882 | 26,106 | 797,701 | 712,295 |
| Current Liabilities | 41,882 | 26,106 | 797,701 | 712,295 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 41,882 | 26,106 | 797,701 | 712,295 |
| Common Stock | 11.9M | 11.9M | 10.6M | 10.6M |
| Capital Stock | 11.9M | 11.9M | 10.6M | 10.6M |
| Retained Earnings | -8.1M | -7.9M | -8.5M | -9.0M |
| Common Stock Equity | 4.0M | 4.0M | 2.1M | 1.7M |
| Stockholders Equity | 4.0M | 4.0M | 2.1M | 1.7M |
| Total Equity Gross Minority Interest | 4.0M | 4.0M | 2.1M | 1.7M |
| Total Capitalization | 4.0M | 4.0M | 2.1M | 1.7M |
| Net Tangible Assets | 4.0M | 4.0M | 2.1M | 1.7M |
| Tangible Book Value | 4.0M | 4.0M | 2.1M | 1.7M |
| Working Capital | 1.7M | 1.9M | 172,665 | -183,196 |
| Invested Capital | 4.0M | 4.0M | 2.1M | 1.7M |
| Share Issued | 18.5M | 18.5M | 8.9M | 8.9M |
| Ordinary Shares Number | 18.5M | 18.5M | 8.9M | 8.9M |
| Dueto Related Parties Current | 2,966 | 5,323 | 771,533 | 672,652 |
| Other Equity Interest | 176,766 | 29,740 | -- | 111,171 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -110,342 | -213,739 | 26,353 | -20,495 |
| Cash Flow From Continuing Operating Activities | -110,342 | -213,739 | 26,353 | -20,495 |
| Stock Based Compensation | 147,026 | 29,740 | 0.00 | -- |
| Change In Working Capital | 20,105 | -26,031 | 82,937 | 72,407 |
| Changes In Account Receivables | 4,329 | -26,905 | -2,469 | 1,055 |
| Change In Receivables | 4,329 | -26,905 | -2,469 | 1,055 |
| Change In Payables And Accrued Expense | 15,776 | 874.00 | 85,406 | 71,352 |
| Change In Payable | 15,776 | 874.00 | 85,406 | 71,352 |
| Other Non Cash Items | -- | -82,468 | -409,000 | -112,500 |
| Capital Expenditure | -194,629 | -121,926 | -43,580 | -50,101 |
| Purchase Of PPE | -- | -- | -- | -50,101 |
| Net PPE Purchase And Sale | -- | -- | -- | -50,101 |
| Sale Of Investment | 366,940 | 300,859 | 197,235 | 15,680 |
| Net Investment Purchase And Sale | 366,940 | 300,859 | 197,235 | 15,680 |
| Investing Cash Flow | 172,311 | 178,933 | 153,655 | -34,421 |
| Cash Flow From Continuing Investing Activities | 172,311 | 178,933 | 153,655 | -34,421 |
| Issuance Of Capital Stock | 0.00 | 606,000 | 0.00 | -- |
| Net Common Stock Issuance | 0.00 | 606,000 | 0.00 | -- |
| Financing Cash Flow | 0.00 | 583,798 | 0.00 | -- |
| Cash Flow From Continuing Financing Activities | 0.00 | 583,798 | 0.00 | -- |
| Changes In Cash | 61,969 | 548,992 | 180,008 | -54,916 |
| Beginning Cash Position | 747,962 | 198,970 | 18,962 | 73,878 |
| End Cash Position | 809,931 | 747,962 | 198,970 | 18,962 |
| Free Cash Flow | -304,971 | -335,665 | -17,227 | -70,596 |
| Income Tax Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Impairment Charge | 13,748 | 11,273 | 10,858 | 14,218 |
| Capital Expenditure Reported | -194,629 | -121,926 | -43,580 | -50,101 |
| Change In Account Payable | 18,133 | -5,384 | -13,475 | -11,314 |
| Change In Prepaid Assets | -- | -- | -- | 0.00 |
| Common Stock Issuance | 0.00 | 606,000 | 0.00 | -- |
| Gain Loss On Investment Securities | -76,190 | -28,859 | -17,235 | 8,850 |
| Gain Loss On Sale Of PPE | 0.00 | -738,000 | 0.00 | -- |
| Net Income From Continuing Operations | -156,142 | 563,230 | 388,583 | 77,780 |
| Net Other Financing Charges | -- | -22,202 | -- | -- |
| Net Other Investing Changes | -- | -121,926 | -43,580 | -50,101 |
| Operating Gains Losses | -76,190 | -766,859 | -17,235 | 8,850 |
| Unrealized Gain Loss On Investment Securities | -58,889 | 57,376 | -29,790 | -81,250 |